GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a remarkable shift in how we treat type 2 diabetes . These new medications function to imitating the body’s own GLP-1 substance , which https://umarywcr931760.verybigblog.com/40723315/glp-1-a-revolutionary-advance-in-glucose-treatment